ArticleJournal of the neurological sciences2021

Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic?

F Tazza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.